2020
DOI: 10.1248/bpb.b20-00747
|View full text |Cite
|
Sign up to set email alerts
|

KB-R7943 Inhibits the Mitochondrial Ca<sup>2+</sup> Uniporter but Not Na<sup>+</sup>–Ca<sup>2+</sup> Exchanger in Cardiomyocyte-Derived H9c2 Cells

Abstract: The effect of KB-R7943, an inhibitor of the plasmalemmal Na + -Ca 2+ exchanger, on mitochondrial Ca 2+ transporters was examined with membrane-permeabilized cardiomyocyte-derived H9c2 cells expressing the fluorescent Ca 2+ indicator, yellow cameleon 3.1, in the mitochondria. KB-R7943, as well as ruthenium red, inhibited the rise in mitochondrial Ca 2+ on increasing the extramitochondrial Ca 2+ concentration from 0 nM to 300 nM. CGP37157, but not KB-R7943, inhibited the decline in mitochondrial Ca 2+ on return … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
3
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 18 publications
(26 reference statements)
0
3
0
Order By: Relevance
“…A further inhibitor, KB-R7943, may be taken into consideration, since it has recently been shown to alleviate P. aeruginosa –triggered inflammatory responses in vivo [ 97 ], and it may have a similar anti-inflammatory effect in the tumor micro-environment, therefore negatively affecting tumor growth. However, this drug is also a potent inhibitor of the plasma membrane (PM) Na + /Ca 2+ exchanger NCX1 [ 98 ] ( contra [ 99 ]) and its tumor-reducing action observed in a murine prostate xenograft model has been ascribed to its effect on the PM exchanger [ 100 ] rather than to inhibition of the mitochondrial channel.…”
Section: Mitochondrial Ion Channels and Their Pharmacological Targeting By Small Moleculesmentioning
confidence: 99%
“…A further inhibitor, KB-R7943, may be taken into consideration, since it has recently been shown to alleviate P. aeruginosa –triggered inflammatory responses in vivo [ 97 ], and it may have a similar anti-inflammatory effect in the tumor micro-environment, therefore negatively affecting tumor growth. However, this drug is also a potent inhibitor of the plasma membrane (PM) Na + /Ca 2+ exchanger NCX1 [ 98 ] ( contra [ 99 ]) and its tumor-reducing action observed in a murine prostate xenograft model has been ascribed to its effect on the PM exchanger [ 100 ] rather than to inhibition of the mitochondrial channel.…”
Section: Mitochondrial Ion Channels and Their Pharmacological Targeting By Small Moleculesmentioning
confidence: 99%
“…Thus, the concentration of KB‐R7943 used in the present study, 20 μM, can effectively block the reverse mode of the NCX without effecting above mentioned proteins in both neurons and astrocytes. It is still controversial whether KB‐R7943 inhibits the mitochondrial Ca 2+ uptake (Brustovetsky et al, 2011; Namekata et al, 2020; Santo‐Domingo et al, 2007; Storozhevykh et al, 2010; Wiczer et al, 2014) in cultured neurons and other cell types. Although during our experiments, we have not observed any abnormal Ca 2+ activity in jRGECO1a expressing neurons, to rule out the possible off‐target of KB‐R7943 on mitochondria, further assessment of neuronal and astrocytic mitochondrial function shall be considered, for instance, using mitochondria tagged GECIs in neurons and astrocytes to access the functionality during the Scc stimulation with the presence of KB‐R7943.…”
Section: Discussionmentioning
confidence: 99%
“…Even though several NCX blockers (KB-R7943, SEA0400, SN-6, and YM-244769) are currently available [82,83], it is quite clear that besides NCX, these compounds also can interact with other membrane proteins [84][85][86]. Another fundamental obstacle is that the selective pharmacological targeting of tissue-specific NCX variants remains unavailable due to an incomplete understanding of the underlying molecular and cellular mechanisms [1,5,7,[9][10][11]60].…”
Section: Discussionmentioning
confidence: 99%